Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Chondrosarcoma × Analgesia × Clear all

Sponsor

Conditions

Pain 3 Vomiting 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Neurotoxicity Syndromes 1 Neoplasms 1 Nausea 1 Multiple Myeloma 1 Mucositis 1 Melanoma 1 Lymphoma 1 Intraoperative Complications 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Depression 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Abnormalities, Radiation-Induced 1

Interventions

HhAntag691 2 toripalimab 1 temsirolimus 1 pegfilgrastim 1 pazopanib 1 liposomal doxorubicin 1 enasidenib 1 angiotensin I (1-7) 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Proton Therapy 1 Pharmacogenomic Testing 1 Microarray Analysis 1 Medicare Part B 1 Magnetic Resonance Spectroscopy 1 Immunologic Techniques 1 Gemcitabine 1 Filgrastim 1 Ferrosoferric Oxide 1 Fentanyl 1 Docetaxel 1 Dasatinib 1 Cyproheptadine 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡